Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

28 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Multiple transcriptional activation of cellular oncogenes in human head and neck solid tumours.
Spandidos DA, Lamothe A, Field JK. Spandidos DA, et al. Among authors: lamothe a. Anticancer Res. 1985 Mar-Apr;5(2):221-4. Anticancer Res. 1985. PMID: 2581495
Clinical relevance of oncogene expression in head and neck tumours.
Field JK, Lamothe A, Spandidos DA. Field JK, et al. Among authors: lamothe a. Anticancer Res. 1986 Jul-Aug;6(4):595-600. Anticancer Res. 1986. PMID: 3019219
A significant increase was found for myc expression in TNM Stage III and IV as compared to the combined stages of I and II. Elevated expression of Ha-ras, Ki-ras and myc oncogenes was found in pleomorphic salivary adenoma (PSA), but at a lower level than SCC. It is
A significant increase was found for myc expression in TNM Stage III and IV as compared to the combined stages of I and II. Elevated
Brachytherapy in the retreatment of patients with new primary head and neck cancer.
Grimard L, Lamothe A, Esche B, Spaans JN. Grimard L, et al. Among authors: lamothe a. J Otolaryngol. 2007 Dec;36(6):327-35. J Otolaryngol. 2007. PMID: 18076842
Radiation-induced low-grade fibromyxoid sarcoma of the sternocleidomastoid muscle.
Marglani O, Commons S, Lamothe A. Marglani O, et al. Among authors: lamothe a. J Otolaryngol. 2007 Oct;36(5):E73-5. J Otolaryngol. 2007. PMID: 18001636 No abstract available.
Is there a role for conservative management for symptomatic laryngopyocele? Case report and literature review.
Ling FT, Lamothe A. Ling FT, et al. Among authors: lamothe a. J Otolaryngol. 2004 Aug;33(4):264-8. doi: 10.2310/7070.2004.03011. J Otolaryngol. 2004. PMID: 15903210 No abstract available.
Lemierre syndrome: presentation of three cases.
Hong P, MacCormick J, Lamothe A, Corsten M. Hong P, et al. Among authors: lamothe a. J Otolaryngol. 2005 Oct;34(5):352-8. doi: 10.2310/7070.2005.34511. J Otolaryngol. 2005. PMID: 16181600 No abstract available.
Interstitial brachytherapy in the management of persistent head and neck disease after definitive external beam radiation therapy.
Grimard L, Esche B, Lamothe A, Spaans JN. Grimard L, et al. Among authors: lamothe a. Brachytherapy. 2009 Jul-Sep;8(3):284-9. doi: 10.1016/j.brachy.2008.12.007. Epub 2009 May 15. Brachytherapy. 2009. PMID: 19446500
Interstitial low-dose-rate brachytherapy in the treatment of recurrent head and neck malignancies.
Grimard L, Esche B, Lamothe A, Cygler J, Spaans J. Grimard L, et al. Among authors: lamothe a. Head Neck. 2006 Oct;28(10):888-95. doi: 10.1002/hed.20422. Head Neck. 2006. PMID: 16721742
Doxorubicin plus metronidazole in the treatment of recurrent or metastatic squamous cell carcinoma of the head and neck.
Stewart DJ, Cripps MC, Lamothe A, Laframboise G, Odell P, Gerin-Lajoie J. Stewart DJ, et al. Among authors: lamothe a. Am J Clin Oncol. 1993 Apr;16(2):113-6. doi: 10.1097/00000421-199304000-00006. Am J Clin Oncol. 1993. PMID: 8452101 Clinical Trial.
Of 23 patients evaluable for response, 2 (9%) achieved complete remissions, 2 (9%) achieved partial remissions, and 4 (18%) were stable (one of whom achieved a minor response). One patient with an inoperable biopsy-proven 4 x 3 x 3 cm recurrence following radiation and sur …
Of 23 patients evaluable for response, 2 (9%) achieved complete remissions, 2 (9%) achieved partial remissions, and 4 (18%) were stable (one …
Cisplatin, cytosine arabinoside, and pentoxifylline in the treatment of squamous cell carcinoma of the head and neck.
Stewart DJ, Cripps MC, Fingert H, Lamothe A, Laframboise G, Gerin-Lajoie J. Stewart DJ, et al. Among authors: lamothe a. Am J Clin Oncol. 1993 Apr;16(2):123-6. doi: 10.1097/00000421-199304000-00008. Am J Clin Oncol. 1993. PMID: 8452103 Clinical Trial.
Nine patients were entered on a Phase I-II study of cisplatin, cytosine arabinoside, and pentoxifylline in the treatment of advanced head and neck cancer. ...
Nine patients were entered on a Phase I-II study of cisplatin, cytosine arabinoside, and pentoxifylline in the treatment of advanced …
28 results
Jump to page
Feedback